Ritonavir Patent Expiration

Ritonavir is Used for treating HIV infection in combination with other antiretroviral agents. It was first introduced by Abbvie Inc in its drug Norvir on Mar 1, 1996. 8 different companies have introduced drugs containing Ritonavir.


Ritonavir Patents

Given below is the list of patents protecting Ritonavir, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Norvir US5484801 Pharmaceutical composition for inhibiting HIV protease Jan 28, 2014

(Expired)

Abbvie
Norvir US5484801

(Pediatric)

Pharmaceutical composition for inhibiting HIV protease Jul 28, 2014

(Expired)

Abbvie
Norvir US5541206 Retroviral protease inhibiting compounds Jul 30, 2013

(Expired)

Abbott
Norvir US5541206 Retroviral protease inhibiting compounds Jul 30, 2013

(Expired)

Abbvie
Norvir US5541206

(Pediatric)

Retroviral protease inhibiting compounds Jan 30, 2014

(Expired)

Abbott
Norvir US5541206

(Pediatric)

Retroviral protease inhibiting compounds Jan 30, 2014

(Expired)

Abbvie
Norvir US5635523 Retroviral protease inhibiting compounds Jul 30, 2013

(Expired)

Abbvie
Norvir US5635523 Retroviral protease inhibiting compounds Jun 03, 2014

(Expired)

Abbott
Norvir US5635523

(Pediatric)

Retroviral protease inhibiting compounds Dec 03, 2014

(Expired)

Abbott
Norvir US5635523

(Pediatric)

Retroviral protease inhibiting compounds Jan 30, 2014

(Expired)

Abbvie
Norvir US5648497 Retroviral protease inhibiting compounds Jul 15, 2014

(Expired)

Abbott
Norvir US5648497 Retroviral protease inhibiting compounds Jul 15, 2014

(Expired)

Abbvie
Norvir US5648497

(Pediatric)

Retroviral protease inhibiting compounds Jan 15, 2015

(Expired)

Abbott
Norvir US5648497

(Pediatric)

Retroviral protease inhibiting compounds Jan 15, 2015

(Expired)

Abbvie
Norvir US5674882 Retroviral protease inhibiting compounds Jul 30, 2013

(Expired)

Abbvie
Norvir US5674882

(Pediatric)

Retroviral protease inhibiting compounds Jan 30, 2014

(Expired)

Abbvie
Norvir US5948436 Pharmaceutical composition Sep 13, 2013

(Expired)

Abbott
Norvir US5948436 Pharmaceutical composition Sep 13, 2013

(Expired)

Abbvie
Norvir US5948436

(Pediatric)

Pharmaceutical composition Mar 13, 2014

(Expired)

Abbott
Norvir US5948436

(Pediatric)

Pharmaceutical composition Mar 13, 2014

(Expired)

Abbvie
Norvir US6037157 Method for improving pharmacokinetics Jun 26, 2016

(Expired)

Abbvie
Norvir US6037157

(Pediatric)

Method for improving pharmacokinetics Dec 26, 2016

(Expired)

Abbvie
Norvir US6232333 Pharmaceutical composition Nov 07, 2017

(Expired)

Abbvie
Norvir US6232333

(Pediatric)

Pharmaceutical composition May 07, 2018

(Expired)

Abbvie
Norvir US6703403 Method for improving pharmacokinetics Jun 26, 2016

(Expired)

Abbvie
Norvir US6703403

(Pediatric)

Method for improving pharmacokinetics Dec 26, 2016

(Expired)

Abbvie
Norvir US7141593 Pharmaceutical formulations May 22, 2020

(Expired)

Abbvie
Norvir US7141593

(Pediatric)

Pharmaceutical formulations Nov 22, 2020

(Expired)

Abbvie
Norvir US7148359 Polymorph of a pharmaceutical Jul 19, 2019

(Expired)

Abbvie
Norvir US7148359

(Pediatric)

Polymorph of a pharmaceutical Jan 19, 2020

(Expired)

Abbvie
Norvir US7364752 Solid dispersion pharamaceutical formulations Nov 10, 2020

(Expired)

Abbvie
Norvir US7364752

(Pediatric)

Solid dispersion pharamaceutical formulations May 10, 2021

(Expired)

Abbvie
Norvir US7432294 Pharmaceutical formulations May 22, 2020

(Expired)

Abbvie
Norvir US7432294

(Pediatric)

Pharmaceutical formulations Nov 22, 2020

(Expired)

Abbvie
Norvir US8268349 Solid pharmaceutical dosage form Aug 25, 2024

(Expired)

Abbvie
Norvir US8268349

(Pediatric)

Solid pharmaceutical dosage form Feb 25, 2025 Abbvie
Norvir US8399015 Solid pharmaceutical dosage form Aug 25, 2024

(Expired)

Abbvie
Norvir US8399015

(Pediatric)

Solid pharmaceutical dosage form Feb 25, 2025 Abbvie
Norvir US8470347 Self-emulsifying active substance formulation and use of this formulation Sep 17, 2026 Abbvie
Norvir US8470347

(Pediatric)

Self-emulsifying active substance formulation and use of this formulation Mar 17, 2027 Abbvie
Norvir US8691878 Solid pharmaceutical dosage form Aug 25, 2024

(Expired)

Abbvie
Norvir US8691878

(Pediatric)

Solid pharmaceutical dosage form Feb 25, 2025 Abbvie



Ritonavir Generics

Several generic applications have been filed for Ritonavir. The first generic version for Ritonavir was by Cipla Ltd and was approved on Jan 15, 2015. And the latest generic version is by Mylan Pharmaceuticals Inc and was approved on Feb 16, 2024.

Given below is the list of companies who have filed for Ritonavir generic.


1. AMNEAL

Amneal Pharmaceuticals Llc has filed for 1 generic for Ritonavir. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet Prescription ORAL AB Sep 17, 2018


2. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 1 generic for Ritonavir. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet Prescription ORAL AB Sep 17, 2018


3. CIPLA

Cipla Ltd has filed for 1 generic for Ritonavir. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet Prescription ORAL AB May 10, 2022


4. HETERO LABS LTD III

Hetero Labs Ltd Unit Iii has filed for 1 generic for Ritonavir. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet Prescription ORAL AB Sep 17, 2018


5. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Ritonavir. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG capsule Discontinued ORAL N/A Dec 3, 2020


6. MYLAN

Mylan Pharmaceuticals Inc has filed for 1 generic for Ritonavir. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG capsule Prescription ORAL N/A Feb 16, 2024